Randomised, Double-Blind, Placebo-Controlled, Parallel Group Trial to Confirm the Efficacy, Safety and Tolerability of Ginkgo biloba Special Extract EGb 761 in Patients Suffering from Mild Mental Impairment (MMI).

Trial Profile

Randomised, Double-Blind, Placebo-Controlled, Parallel Group Trial to Confirm the Efficacy, Safety and Tolerability of Ginkgo biloba Special Extract EGb 761 in Patients Suffering from Mild Mental Impairment (MMI).

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 May 2011

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Mental disorders
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals
  • Most Recent Events

    • 12 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top